Jean-Michel Blanquer's announcement to no longer systematically close classes when positive cases are detected fuels the many debates currently agitating specialists, both on the impact of the youngest in the epidemic dynamic. and on specific measures to be taken with regard to children.
First, the extension of vaccination to 5-11 years.
Thus, on November 15, the learned societies of Pediatrics published a press release to react to the announcement of the US Food and Drug Administration (FDA) authorizing vaccination in 5-11 year olds.
In essence, the press release advocates for the moment a
status quo
.
For pediatricians, “
the collective benefit of immunizing young children is less marked than for young adolescents, because it has been shown that they were infected less often and were outside the family environment, less often at the outset. secondary cases
”.
A reverse opinion from that issued a few days later (November 25) by the European Medicines Agency (EMA) which recommends the approval of vaccination in 5-11 year olds with the Pfizer / Cominarty vaccine.
This article is for subscribers only.
You have 72% left to discover.
Pushing back the limits of science is also freedom.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
